A case report highlights the long-term response to pembrolizumab in a patient with metastatic metaplastic breast carcinoma. This finding may inform future treatment strategies for this rare breast cancer subtype.
long term response to pembrolizumab in metastatic metaplastic breast carcinoma a case report
Original title: “Long-Term Response to Pembrolizumab in Metastatic Metaplastic Breast Carcinoma: A Case Report.”